Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients

Transplantation

Volumn 49, Issue 1, 1990, Pages 115-121

  Rabinowich, Hanna ^a   Zeevi, Adriana ^a   Paradis, Irvin L ^a   Yousem, Samuel A ^a   Dauber, James H ^a   Kormos, Robert ^a   Hardesty, Robert L ^a   Griffith, Bartley P ^a   Duquesnoy, Rene J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; LYMPHOCYTE TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; FEMALE; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMAN; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0025169731     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199001000-00026     Document Type: Article

References (28)

1. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306: 557.
2. Jamieson S, Baldwin J, Stinson E, et al. Clinical heart-lung transplantation. Transplantation 1984; 37: 81.
3. Griffith BP, Hardesty RL, Trento A, et al. Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg 1987; 43: 6.
4. Veith FJ. Lung transplantation in perspective. N Engl J Med 1986; 314: 1186.
5. Hutter JA, Despins P, Higenbottam T, Stewart S, Wallwork J. Heart-lung transplantation: better use of resources. Am J Med 1988; 85: 4.
6. Dummer JS, Montero CG, Griffith BP, et al. Infections in heartlung transplant recipients. Transplantation 1986; 41: 725.
7. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86: 824.
8. Yousem SA, Burke CM, Billingham ME. Pathologie pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16: 911.
9. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of airways after pulmonary transplantation. Ann Surg 1988; 208: 371.
10. Harjula A, Baldwin JC, Starnes VA, et al. Proper donor selection of heart-lung transplantation. J Thorac Cardiovasc Surg 1987;94: 874.
11. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin EC. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented suppression. Ann Inter Med 1987; 107: 300.
12. Storer DE, Zaman MB, Hajdu SI, Lange M, Gold J, Armstrong D. Bronchoalveolar lavage in diagnosis of diffuse pulmonary infiltrates in immunosuppressed host. Ann Intern Med 1984; 101: 1.
13. Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of pneumocystis carinii infection after lung-heart transplantation: implications for lung defense and allograft survival. Am Rev Respir Dis 1988; 137: 1268.
14. Burke CM, Glanville AR, Macoviak JA, O’Connell BM, Tazelaar HP, Baldwin JC. The spectrum of cytomegalovirus infection following human heart-lung transplantation. J Heart Transplant 1986; 5: 267.
15. Paradis IR, Dauber JH, Rabin BS. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 855.
16. Zeevi A, Fung JJ, Paradis IL, et al. Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant 1985; 4: 417.
17. Fung JJ, Zeevi A, Kaufman C, et al. Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol 1985; 14: 287.
18. Zeevi A, Fung JJ, Paradis IL, et al. Bronchoalveolar macrophage lymphocyte reactivity in heart-lung transplant recipients. Transplant Proc 1987; 19: 2537.
19. Paradis IL, Marrari M, Zeevi A, et ài. HLA phenotype o f lung lavage cells following heart-lung transplantation. J Heart Transplant 1985; 4: 422.
20. Paradis IL, Grgurich WF, Dummer JS, Decker A, Dauber JH. Rapid detection of CMV pneumonia from lung lavage cells. Am Rev Respir Dis 1988; 138: 697.
21. Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46: 532.
22. Higenbottam T, Stewart S, Penketh A, Wallwork J. The diagnosis of lung rejection and opportunistic infection by transbronchial lung biopsy. Transplant Proc 1987; 19: 3777.
23. Grundy JE, Reid MF. The effect of primary and secondary infection with cytomegalovirus on the host response to alloantigens. Transplant Proc 1986; 17: 592.
24. Kelly CD, Welte K, Murray WH. Antigen induced human interferon production: differential dependence on interleukin-2 and its receptor. J Immunol 1987; 139: 2325.
25. Von Willebrand E, Pettersson E, Ahonen J, Hayry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 354.
26. Romaniuk A, Prop J, Petersen AH, Neiuwenhuis P, Wildevuur CRH. Increased expression of class II major histocompatibility complex antigens in untreated and cyclosporine-treated rat lung allografts. J Heart Transplant 1986; 5: 455.
27. Grine PF, Mayewski RJ, Mushlin AF, Greenland P. Selection and interpretation of diagnostic tests and procedures. Ann Intern Med 1981; 94: 553.
28. Zeevi A, Rabinowich H, Paradis I, et al. Lymphocytes activation in bronchoalveolar lavages from heart lung transplant recipients. Transplant Proc 1988; 20: 189.